tiprankstipranks
Altimmune to Participate at Two Upcoming Investor Conferences
PremiumPress ReleasesAltimmune to Participate at Two Upcoming Investor Conferences
10d ago
Is ALT a Buy, Before Earnings?
PremiumPre-Earnings
Is ALT a Buy, Before Earnings?
10d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
15d ago
Altimmune call volume above normal and directionally bullish
PremiumThe FlyAltimmune call volume above normal and directionally bullish
17d ago
Altimmune downgraded to Neutral at Guggenheim on pemvidutide’s uncertain future
PremiumThe Fly
Altimmune downgraded to Neutral at Guggenheim on pemvidutide’s uncertain future
18d ago
Altimmune downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Altimmune downgraded to Neutral from Buy at Guggenheim
18d ago
Unusually active option classes on open March 27th
PremiumThe FlyUnusually active option classes on open March 27th
2M ago
Options Volatility and Implied Earnings Moves Today, March 27, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 27, 2024
2M ago
Altimmune reports Q4 EPS (54c), consensus (43c)
PremiumThe Fly
Altimmune reports Q4 EPS (54c), consensus (43c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100